<DOC>
	<DOCNO>NCT02126137</DOCNO>
	<brief_summary>Infection hepatitis C virus ( HCV ) affect 170 million people World 80.000 Chile . It cause deaths HIV infection US lead cause liver transplantation Chile . Even though treatment evolve new direct antiviral agent ( DAAs ) increase response rate , several issue new approach , include increase toxicity , need use interferon ribavirin , complex algorithm treatment , high cost , limited effectivity certain group ( liver transplant patient ) drug interaction . Treatments target host factor require viral cycle become increasingly explore alternative complement DAAs . It recently describe Niemann-Pick C1-like 1 ( NPC1L1 ) , intestinal receptor cholesterol , serve entry factor HCV . NPC1L1 , therefore , key transporter enterohepatic cycle cholesterol . NPC1L1 block ezetimibe , approve generally safe drug use management hypercholesterolemia . Our hypothesis posit block HCV entry hepatocyte intestinal HCV reabsorption ezetimibe may antiviral effect . In study , administer ezetimibe 20 mg/d 20 patient stable chronic hepatitis C 12 week assess change HCV RNA core antigen plasma , bile feces .</brief_summary>
	<brief_title>Pilot Study Ezetimibe Chronic Hepatitis C Virus ( HCV ) Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Inclusion criterion : Chronic hepatitis C define detectable HCV RNA 6 month . Age &gt; 18 year old . Compensated liver disease ( bilirubin &lt; 3mg/dL , unless GilbertÂ´s syndrome , albumin &gt; 3 g/dL , INR &lt; 2 , hepatic encephalopathy , ascites recent 1 month history variceal bleeding ) . HCV RNA level &gt; 10.000 IU/mL . Signed informed consent document . Exclusion criterion : History cholecystectomy know gallstone . Current HCV antiviral treatment . Medications dyslipidemia precede 2 month . Abdominal surgery could alter biliary intestinal anatomy . Evidence sitosterolemia . Negative pregnancy test urine ( female ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>HCV</keyword>
	<keyword>Ezetimibe</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Host</keyword>
</DOC>